Jiaqi Lu
Xinjiang Uyhur Autonomous Region. No.1, Health Road
Kashgar, 844000, China
Kashgar, 844000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
MOF-on-MOF-Derived CeO2/Fe@C Composites for Tunable Low-Frequency Electromagnetic Wave Absorption.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: March 04, 2026
Natural Killer Cell Therapy in Ovarian Cancer: From Preclinical Potentials to Clinical Applications and Combination Strategies.
Journal: International journal of biological sciences
Published: December 19, 2025
A top-down neural circuit for affective-motivational responses of pain relief induced by electroacupuncture.
Journal: Chinese medicine
Published: September 25, 2025
Subcutaneous Neuromodulation Activates Central Pain-Suppression Pathways for Analgesia.
Journal: CNS neuroscience & therapeutics
Published: July 20, 2025
Promoting electromagnetic wave absorption for conductive metal-organic frameworks through crystal morphology controlling.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: July 14, 2025
Relationships between lateral hypothalamic orexin circuits and electroacupuncture-induced mitigation of anxiety in a post-traumatic stress disorder model.
Journal: Brain research bulletin
Published: June 13, 2025
Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: February 03, 2025
Fabrication of flower-like CoFe/C composites derived from ferrocene-based metal-organic frameworks: an in situ growth strategy toward high-efficiency electromagnetic wave absorption.
Journal: Nanoscale
Published: September 18, 2024
Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites.
Journal: Cancer research
Published: September 04, 2024
Immunosuppressive JAG2+ tumor-associated neutrophils hamper PD-1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells.
Journal: Cancer communications (London, England)
Published: June 17, 2024
C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer.
Journal: Oncoimmunology
Published: October 04, 2023
Last Updated: 09/26/2026